EviPress
Conventional compressed tablets and relevant solid-dose applications
THE EVI PLATFORM
Engineered Excipient Systems for Modern Tablet Manufacturing
BELNOVA’s Evi Platform brings together dosage-form-specific excipient systems for conventional compressed tablets, orally disintegrating tablets and chewable formulations. Each product provides a prepared excipient pathway designed to simplify formulation evaluation and support more consistent manufacturing decisions.
Dosage-form pathways
01
EviPress
Conventional Tablets
02
EviMelt
ODTs and Fast-Melting Tablets
03
EviChew
Chewable Tablets
Platform overview
One Platform. Three Dosage-Form Pathways.
The Evi Platform helps formulation and manufacturing teams begin with an excipient system suited to the intended dosage form. It provides a structured starting point for evaluation, while each finished formulation remains specific to its materials, process and validation plan.
EviMelt
Orally disintegrating and fast-melting tablets
EviChew
Chewable tablet formulations
Select a pathway
Start with the dosage form you are building.
Each product is presented as a focused formulation pathway, with the product description and technical direction visible before a team begins its evaluation.
Conventional Tablets
EviPress
EviPress is BELNOVA’s proprietary, pre-formulated direct-compression excipient blend for industrial tablet and capsule formulation applications.
Flow support
Compression support
Formulation consistency
Production repeatability
ODTs and Fast-Melting Tablets
EviMelt
EviMelt is a proprietary, flavor-ready direct-compression excipient system developed for orally disintegrating tablets. It is intended to reduce the need to balance multiple individual excipients while supporting formulation and manufacturing evaluation.
Sweet: Sorbitol DC Formula
Cool: Mannitol DC Formula
Chewable Tablets
EviChew
EviChew is a directly compressible excipient blend developed for chewable tablet formulations, with attention to compression behavior, texture and the finished product’s sensory profile.
Mannitol DC
Sorbitol DC
Compare directions
Three product directions, clearly framed.
Use the dosage form, available formulation direction and evaluation focus to frame the next conversation with BELNOVA.
| Product | Dosage form | Available direction | Evaluation focus |
|---|---|---|---|
| EviPress | Conventional compressed tablets | Pre-formulated direct-compression excipient blend | Flow, compression and repeatability |
| EviMelt | ODTs and fast-melting tablets | Sorbitol DC or Mannitol DC formula | Disintegration, compression and mouthfeel |
| EviChew | Chewable tablets | Mannitol DC or Sorbitol DC formula | Compression, texture and sensory profile |
EviPress
Dosage form
Conventional compressed tablets
Available direction
Pre-formulated direct-compression excipient blend
Evaluation focus
Flow, compression and repeatability
EviMelt
Dosage form
ODTs and fast-melting tablets
Available direction
Sorbitol DC or Mannitol DC formula
Evaluation focus
Disintegration, compression and mouthfeel
EviChew
Dosage form
Chewable tablets
Available direction
Mannitol DC or Sorbitol DC formula
Evaluation focus
Compression, texture and sensory profile
Choose by dosage form
Follow the formulation pathway.
A simple starting sequence can help bring the relevant technical questions into focus earlier.
Technical perspective
A Prepared Starting Point, Not a Substitute for Validation
Each Evi product is intended to provide a more structured excipient starting point, but performance must be evaluated using the customer’s complete formulation and production conditions.
Evaluation checklist
The following considerations help keep evaluation focused on the complete product and process context.
Customers add their active ingredient and any required flavor components.
Material compatibility must be evaluated in the complete formulation.
Finished-tablet disintegration, hardness, friability, taste and stability must be validated where relevant.
Tooling, compression settings and production conditions can affect finished-product performance.
Product-specific documentation should be requested from BELNOVA where applicable.
Sample and technical support
Find the Right Evi Pathway for Your Formulation
Tell BELNOVA about your dosage form, active ingredients, production stage and formulation priorities. The team can help identify the most relevant product and documentation pathway for evaluation.